"While we can't speak to specific examples cited in [Thursday's] report, this partisan exercise is clearly designed to garner support for an extreme bill that will erode Medicare protections and access to treatments for seniors," said the Pharmaceutical Research and Manufacturers of America, a major lobbying group.
House report: Top drugmakers spend more on investor perks than R&D
→
Nevada coalition wants drugmakers to reimburse diabetics
→
